Decreased erythromycin use after antimicrobial reimbursement restriction for undocumented bacterial upper respiratory tract infections significantly reduced erythromycin resistance in Streptococcus pyogenes in Taiwan.
Hsueh
Po-Ren
PR
Shyr
Jainn-Ming
JM
Wu
Jiunn-Jong
JJ
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D004282:Documentation; D024881:Drug Resistance, Bacterial; D004363:Drug Utilization; D004917:Erythromycin / Q000627:therapeutic use*; D006801:Humans; D009313:National Health Programs / Q000458:organization & administration; D012051:Reimbursement Mechanisms / Q000458:organization & administration*; D012141:Respiratory Tract Infections / Q000175:diagnosis* / Q000188:drug therapy / Q000382:microbiology; D013290:Streptococcal Infections / Q000453:epidemiology / Q000382:microbiology; D013297:Streptococcus pyogenes / Q000187:drug effects*; D013624:Taiwan / Q000453:epidemiology
D000900:Anti-Bacterial Agents; D004917:Erythromycin